CA
NZ
UK
AU
IND
US
…
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | -17.52M | -11.16M | -20.20M | -14.52M | -19.57M |
| Net income | -17.52M | -11.16M | -20.21M | -14.53M | -19.58M |
| Selling general administrative | 13.52M | 13.46M | 18.25M | 17.58M | 19.04M |
| Gross profit | 5.12M | 5.83M | 4.98M | 4.75M | 4.49M |
| Reconciled depreciation | 0.42M | 0.31M | 0.32M | 0.37M | 0.49M |
| Ebit | -6.96M | -10.84M | -17.63M | -17.17M | -19.53M |
| Ebitda | -6.55M | -10.53M | -17.27M | -16.72M | -19.04M |
| Depreciation and amortization | 0.42M | 0.31M | 0.36M | 0.45M | 0.49M |
| Operating income | -11.11M | -10.99M | -17.63M | -17.17M | -19.53M |
| Other operating expenses | 19.38M | 19.73M | 26.49M | 25.71M | 27.45M |
| Interest expense | 10.55M | 5.61M | 3.48M | 9.25M | 0.04M |
| Tax provision | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Net interest income | -10.55M | -5.61M | -3.48M | -9.25M | 0.00M |
| Income tax expense | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M |
| Total revenue | 8.27M | 8.74M | 8.86M | 8.54M | 7.92M |
| Total operating expenses | 16.23M | 16.81M | 22.61M | 21.93M | 24.02M |
| Cost of revenue | 3.15M | 2.91M | 3.88M | 3.79M | 3.43M |
| Total other income expense net | -6.41M | -0.17M | -2.57M | 2.65M | -0.04M |
| Net income from continuing ops | -17.52M | -11.16M | -16.60M | -14.53M | -19.58M |
| Net income applicable to common shares | - | - | - | -14.53M | -19.58M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 6.12M | 9.86M | 9.77M | 24.67M | 30.42M |
| Other current assets | 0.70M | 0.32M | 0.46M | 0.40M | 0.33M |
| Total liab | 3.49M | 3.33M | 6.78M | 12.32M | 4.47M |
| Total stockholder equity | 2.62M | 6.53M | 2.99M | 12.36M | 25.95M |
| Other current liab | 0.79M | 0.68M | 0.58M | 2.22M | 0.04M |
| Common stock | - | 0.47M | 0.00M | 6.87M | 0.00M |
| Capital stock | 0.01M | 0.00M | 0.22M | 0.00M | 0.00M |
| Retained earnings | -316.31M | -298.79M | -287.63M | -267.42M | -252.92M |
| Other liab | - | - | - | 6.87M | 0.18M |
| Other assets | - | - | - | 0.02M | 0.02M |
| Cash | 1.08M | 5.09M | 3.80M | 17.74M | 24.20M |
| Total current liabilities | 3.03M | 2.56M | 3.17M | 4.69M | 3.31M |
| Current deferred revenue | - | - | - | - | 1.66M |
| Net debt | -0.76M | -4.55M | -2.82M | -16.75M | -23.03M |
| Short term debt | 0.26M | 0.24M | 0.22M | 0.22M | 0.19M |
| Short long term debt total | 0.33M | 0.55M | 0.98M | 0.98M | 1.18M |
| Other stockholder equity | 318.93M | 305.37M | 290.43M | 272.87M | 278.87M |
| Property plant equipment | - | - | - | 1.88M | 2.27M |
| Total current assets | 5.19M | 8.86M | 8.21M | 22.77M | 28.13M |
| Net tangible assets | - | - | - | 12.36M | 25.95M |
| Short term investments | - | - | 0.00M | 0.57M | - |
| Net receivables | 1.49M | 1.73M | 1.95M | 1.41M | 0.75M |
| Inventory | 1.91M | 1.72M | 2.00M | 2.66M | 2.84M |
| Accounts payable | 1.98M | 1.64M | 2.38M | 2.25M | 1.41M |
| Accumulated other comprehensive income | 0.01M | -0.05M | -0.03M | 0.04M | -0.01M |
| Non currrent assets other | 0.27M | 0.02M | 0.12M | 0.02M | 0.02M |
| Non current assets total | 0.93M | 1.01M | 1.56M | 1.90M | 2.29M |
| Capital lease obligations | 0.33M | 0.55M | 0.76M | 0.98M | 1.18M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -0.06M | 15.12M | 14.73M | -0.22M |
| Change to liabilities | - | - | - | 1.28M | -0.21M |
| Total cashflows from investing activities | -0.09M | -0.06M | - | 14.73M | -0.22M |
| Net borrowings | - | 0.00M | - | -0.03M | -0.03M |
| Total cash from financing activities | 6.94M | 10.96M | 3.68M | 9.42M | 27.87M |
| Change to operating activities | - | - | - | -0.16M | 0.10M |
| Net income | -17.52M | -11.16M | -20.21M | -14.53M | -19.58M |
| Change in cash | -3.90M | 1.29M | -13.94M | 8.99M | 9.77M |
| Begin period cash flow | 5.09M | 3.80M | 17.74M | 8.74M | 14.44M |
| End period cash flow | 1.19M | 5.09M | 3.80M | 17.74M | 24.20M |
| Total cash from operating activities | -10.81M | -9.59M | -17.94M | -15.15M | -17.88M |
| Issuance of capital stock | 6.94M | 8.43M | 11.56M | 9.45M | 27.90M |
| Depreciation | 0.42M | 0.31M | 0.36M | 0.37M | 0.49M |
| Dividends paid | - | 0.54M | 2.30M | - | - |
| Change to inventory | -0.19M | 0.28M | 0.70M | 0.14M | -0.14M |
| Change to account receivables | 0.23M | 0.22M | -0.55M | -0.66M | 0.15M |
| Sale purchase of stock | - | - | 2.33M | - | - |
| Other cashflows from financing activities | - | 3.04M | 0.33M | 9.42M | 0.00M |
| Change to netincome | - | - | - | -1.59M | 1.31M |
| Capital expenditures | 0.09M | 0.06M | 0.25M | 0.12M | 0.22M |
| Change in working capital | -0.25M | -0.30M | -1.42M | 0.60M | -0.10M |
| Stock based compensation | 0.13M | 0.48M | 0.67M | 0.86M | 1.31M |
| Other non cash items | 6.42M | 1.09M | 1.31M | -2.46M | 2.50M |
| Free cash flow | -10.90M | -9.65M | -18.18M | -15.27M | -18.10M |
Sector: Healthcare Industry: Medical Devices
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| NUWE Nuwellis Inc |
-0.10 1.73% |
5.68 | - | - | 0.30 | 0.18 | 0.00 | -0.34 |
| ABT Abbott Laboratories |
1.63 1.56% |
106.20 | 25.97 | 17.24 | 3.57 | 3.20 | 3.81 | 16.75 |
| MDT Medtronic PLC |
-0.57 0.59% |
96.54 | 26.60 | 15.87 | 3.35 | 2.08 | 3.90 | 14.12 |
| SYK Stryker Corporation |
-19.89 6.38% |
291.86 | 29.23 | 16.86 | 4.18 | 4.51 | 4.63 | 17.16 |
| SEMHF Siemens Healthineers AG |
-0.11 0.22% |
47.69 | 39.57 | 21.32 | 3.01 | 3.29 | 2.95 | 16.92 |
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.
12988 Valley View Road, Eden Prairie, MN, United States, 55344
952 345 4200
38
| Name | Title | Year Born |
|---|---|---|
| Mr. Nestor Jaramillo Jr. | Pres, CEO & Director | 1957 |
| Mr. Neil P. Ayotte Esq. | Sr. VP, Gen. Counsel, Sec. & Chief Compliance Officer | 1963 |
| Ms. Lynn L. Blake CPA, M.B.A. | Chief Financial Officer | 1967 |
| Mr. Rob Scott | Sr. Director of Financial Planning & Analysis and Interim Principal Accounting Officer | NA |
| Mr. William Colon M.D. | VP of Marketing | NA |
| Mr. John Kowalczyk | VP of Sales | NA |
| Ms. Sandra Eayrs | Chief HR Officer | NA |
| Mr. Vitaliy Epshteyn | Sr. VP of Operations & Engineering | 1978 |
| Mr. Paul Wotta | Corp. Controller | 1957 |
| Mr. Laurent Duhoux | VP of International Bus. Devel. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...